Keynote speakers include leaders from Bayer,
Genentech, Novo Nordisk, and Takeda sharing strategies for
effective commercialization and engagement
PLEASANTON, Calif., April 17,
2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV)
today announced that leaders from Bayer, Genentech, Novo Nordisk,
Takeda, and others will be among the keynote speakers at the 2024
Veeva Commercial Summit, May 7-8 in
Boston. Commercial and medical
affairs professionals will share how they are innovating across
content, data and analytics, and customer interactions to advance
the future of customer-centric engagement.
Veeva CEO Peter Gassner will
headline the opening keynote, sharing how the recent delivery of
Veeva Vault CRM fits into Veeva's commercial vision. Attendees will
see the first demo of Veeva Vault CRM Campaign Manager, as well as
a demo of advancements in modern data and connected software with
Veeva Compass.
Leading and emerging biopharmas will headline the keynotes, with
topics including:
- ANI, Bayer, and Takeda, driving a modern commercial data
approach to gain deeper patient and healthcare professional (HCP)
insights.
- Genentech, leveraging marketing analytics to improve
business impact for its brands.
- Idorsia and Novo Nordisk, establishing a strong
operational foundation to effectively advance patient-centric
medical impact metrics.
- Leading biopharma, unifying global content strategy
across commercial and medical to enhance the overall patient
experience.
- Novo Nordisk, advancing its commercial foundation with
Veeva Vault CRM at its core to increase agility.
- Takeda, using scientific expert intelligence, connected
data, and cross-functional collaboration to improve field
engagement.
"To be truly customer-centric in today's increasingly complex
environment requires even greater alignment and collaboration
across sales, marketing, and medical," said Paul Shawah, executive vice president at Veeva.
"Veeva is committed to commercial execution and bringing life
sciences leaders together to share learnings and fresh ideas around
commercial strategies and customer engagement to move the industry
forward."
One of the largest industry events in North America for commercial and medical
affairs professionals, Veeva Commercial Summit will host over 1,700
leaders across more than 100 sessions. Life sciences industry
professionals can register and see the full agenda and program
details at veeva.com/Summit.
Additional Information
For more on Veeva Commercial
Summit, visit: veeva.com/Summit
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-K for the fiscal year ended January 31, 2024, which you can
find here (a summary of risks which may impact our
business can be found on pages 9 and 10), and in our subsequent SEC
filings, which you can access at sec.gov.
Contact:
Alison Borris
Veeva Systems
925-226-8821
alison.borris@veeva.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biopharma-leaders-come-together-at-veeva-commercial-summit-to-advance-customer-centric-engagement-302119107.html
SOURCE Veeva Systems